SS 11/26/2018 OTC n TA Updates Authorized: 2,000,000,000 Issued: 1,547,798,629 no change Restricted: 300,014,239 no change
The company Currently Produces and Markets 300 Plus generic pharmaceutical Products along with dermatology and nutraceutical Products!
The company currently has manageable capital for its operations, with reduced operational costs.
Mr. Night’s thorough experience in providing leadership to various companies and his contacts and experience in emerging markets will strengthen the position of the Company and allow for large scale distribution of generic drug lines
Mr. Night states that the company has not issued any stock to anyone including promoters, officers, directors, and/or employees in the last several years. The purpose of the stock issued in April 2018 was to retire financial notes as explained by corporate counsel. Company management has no immediate plans to engage in any major restructuring of its share structure.